• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Hemorrhage, Cerebral (1889)
Event Date 11/26/2015
Event Type  Death  
Manufacturer Narrative
Daou, b.Et al.(2015).Pipeline embolization device in the treatment of recurrent previously stented cerebral aneurysms.American journal of neuroradiology, 37(5), 849-855.Doi:10.3174/ajnr.A4613 the pipeline devices will not be returned for evaluation as they remain implanted in the patients.Based on the information provided in the article, there did not appear to have been any defects of the devices during use.The events occurred in the patients post-procedure and the causes could not be conclusively determined from the provided information.Mdrs related to this article: 2029214-2017-00521 2029214-2017-00522 2029214-2017-00523.
 
Event Description
Medtronic literature review found reports of patient deaths after pipeline implantation.The purpose of this article was to evaluate the efficacy and safety of the pipeline embolization device (ped) in the treatment of recurrent, previously-stented aneurysms.The authors identified 21 patients with previously-stented recurrent aneurysms who underwent retreatment with ped.These patients were compared with 63 patients who had treatment with the ped without prior stent placement.In the previously-stented group, four patients had an unfavorable outcome (19%) including 1 patient with an mrs of 6 (death).In the ped-only group, one patient experienced a right intracerebral hemorrhage after ped treatment of a right ica aneurysm and died (mrs 6).In addition, the article states that in the ped-only group, seven patients did not have available angiograms; this included three patients who died following the procedure.The causes of death were not provided in the article.Mortality was similar in both the previously-stented and ped-only groups (4.76%).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key6517580
MDR Text Key73556636
Report Number2029214-2017-00523
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 03/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/24/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/28/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-